Abstract
1. We have characterized and quantified specific binding of [ 3H]-flunitrazepam (FNZ: (benzodiazepine), [ 3H]-naloxone (NAL: (opiate) and [ 3h]cgp-12177(CGP: (beta-adrenergic) to thick slices (230–400 μm) of mouse and rat brain. 2. The binding sites are stereospecific, saturable and of high affinity. In all cases, the binding of the ligands is readily reversible and demonstrates the appropriate drug specificity. 3. In mouse brain [ 3H]-NAL binding is elevated by chronic treatment with naloxone (via capsules). 4. We have been unsuccessful in quantifying beta adrenoreceptors with the archetypal ligand [ 3H]-dihydroalprenolol (DHA). However, the use of [ 3H]-CGP 12177 enabled us to detect high-affinity beta adrenoreceptors in brain slices. 5. [ 3H]-CGP also permits the demonstration of rapid and reversible agonist-induced down-regulation (internalization) of beta binding sites. 6. We have been successful in quantifying beta adrenergic sites in single pineal glands of rat and hamster.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Progress in Neuropsychopharmacology & Biological Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
